Related Experiment Video
Updated: Aug 6, 2026
08:50
Thrombus Profiling Assay: A Microfluidics-Based Platform for Comprehensively Characterizing Biomechanical Thrombogenesis
Published on: January 9, 2026
Who should be tested for thrombophilia?
1Department of Medical and Surgical Sciences, University of Padua Medical School, Padua, Italy. paolo.simioni@unipd.it
Current Opinion in Hematology
|August 5, 2006
Summary
Screening for thrombophilia can identify individuals at higher risk of venous thromboembolism (VTE) and its recurrence. This testing is particularly beneficial for young VTE patients and women with pregnancy complications.
Area of Science:
- Medical Genetics
- Hematology
- Thrombosis Research
Background:
- Inherited thrombophilia increases the risk of venous thromboembolism (VTE).
- Understanding thrombophilia is crucial for managing VTE and related complications.
- Expert opinions and available data guide screening recommendations.
Purpose of the Study:
- To identify individuals who would most benefit from thrombophilia screening.
- To clarify the role of thrombophilia in VTE recurrence and pregnancy outcomes.
- To inform clinical management strategies based on thrombophilia status.
Main Methods:
- Review of recent studies and meta-analyses on thrombophilia and VTE.
- Analysis of data on inherited thrombophilia and recurrence risk.
- Evaluation of expert opinions on screening indications.
Main Results:
- Thrombophilia screening can identify carriers at increased risk of VTE recurrence.
- Screening may be beneficial for young VTE patients and asymptomatic family members.
- Thrombophilia is associated with early fetal losses, suggesting screening for women with adverse pregnancy outcomes.
Conclusions:
- Screening for thrombophilia is recommended for young VTE patients.
- Identifying carriers in thrombophilic families can aid in preventive strategies.
- Thrombophilia screening in women with pregnancy complications may guide prophylactic treatment.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
01:30Venous Thrombosis I: Introduction
Venous thrombosis, the most common disorder of the veins, involves the formation of a thrombus or blood clot associated with vein inflammation. It can be classified as either superficial vein thrombosis or deep vein thrombosis.Superficial Vein Thrombosis: This involves the formation of a thrombus in a superficial vein, usually the greater or lesser saphenous vein. Though less severe than deep vein thrombosis (DVT), SVT can lead to complications if untreated.Deep Vein Thrombosis (DVT): This...